Legend Biotech Corp Adr (LEGN)

Apr 29, 2026

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 29, 2026

Apr 26, 2026

Legend Biotech (LEGN) moves 18.4% higher: Will this strength last? - MSN

Apr 26, 2026

Apr 25, 2026

Legend Biotech Corporation Sponsored ADR $LEGN Stock Holdings Lowered by Matthews International Capital Management LLC - MarketBeat

Apr 25, 2026

Apr 21, 2026

Legend Biotech (LEGN) Moves 18.4% Higher: Will This Strength Last? - Yahoo Finance

Apr 21, 2026

Apr 21, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on M&A activity By Investing.com - Investing.com South Africa

Apr 21, 2026

Apr 21, 2026

Raymond James reiterates Legend Biotech stock rating on strong trial data - Investing.com

Apr 21, 2026

Apr 21, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on M&A activity - Investing.com

Apr 21, 2026

Apr 20, 2026

Why Legend Biotech Stock Crushed the Market on Monday - The Motley Fool

Apr 20, 2026

Apr 20, 2026

RBC Capital reiterates Legend Biotech stock rating on pharma interest By Investing.com - Investing.com India

Apr 20, 2026

Apr 20, 2026

Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday - Benzinga

Apr 20, 2026

Apr 20, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on pipeline progress - Investing.com

Apr 20, 2026

Apr 20, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on pipeline progress By Investing.com - Investing.com India

Apr 20, 2026

Apr 17, 2026

HC Wainwright Boosts Earnings Estimates for Legend Biotech - MarketBeat

Apr 17, 2026

Apr 16, 2026

Legend Biotech (NASDAQ:LEGN) Trading 6.3% HigherStill a Buy? - MarketBeat

Apr 16, 2026

Apr 16, 2026

Q2 EPS Estimates for Legend Biotech Lowered by HC Wainwright - MarketBeat

Apr 16, 2026

Apr 15, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on strong Carvykti sales - Investing.com

Apr 15, 2026

Apr 15, 2026

H.C. Wainwright reiterates Legend Biotech stock rating on strong Carvykti sales By Investing.com - Investing.com South Africa

Apr 15, 2026

Apr 04, 2026

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 04, 2026

Apr 01, 2026

Legend Biotech (LEGN) Q2 2025 Earnings Transcript - The Globe and Mail

Apr 01, 2026

Mar 31, 2026

Legend Biotech Corporation Sponsored ADR $LEGN Shares Bought by SG Americas Securities LLC - MarketBeat

Mar 31, 2026

Mar 28, 2026

Legend Biotech (NASDAQ:LEGN) CEO Sells $87,138.72 in Stock - MarketBeat

Mar 28, 2026

Mar 27, 2026

Huang Ying, CEO of Legend Biotech, sells $87k in shares - Investing.com India

Mar 27, 2026

Mar 27, 2026

Recent Research Analysts’ Ratings Updates for Legend Biotech (LEGN) - Defense World

Mar 27, 2026

Mar 22, 2026

Virtus Biotech ETF Holdings - Quiver Quantitative

Mar 22, 2026

Mar 21, 2026

Hudson Bay Capital Management LP Has $7.17 Million Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Mar 21, 2026

Mar 19, 2026

Legend Biotech Q1 EPS Estimate Decreased by HC Wainwright - MarketBeat

Mar 19, 2026

Mar 15, 2026

Braidwell LP Decreases Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Mar 15, 2026

Mar 15, 2026

ArrowMark Colorado Holdings LLC Cuts Position in Axis Capital Holdings Limited $AXS - Defense World

Mar 15, 2026

Mar 13, 2026

UiPath (NYSE:PATH) Price Target Cut to $13.00 by Analysts at Wells Fargo & Company - Defense World

Mar 13, 2026

Mar 13, 2026

Capital International Investors Sells 140,873 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Mar 13, 2026

Mar 13, 2026

iShares MBS ETF $MBB Shares Acquired by Capital International Investors - Defense World

Mar 13, 2026

Mar 13, 2026

CLEAR Secure, Inc. (NYSE:YOU) Receives Average Recommendation of “Hold” from Analysts - Defense World

Mar 13, 2026

Mar 13, 2026

Royal Bank Of Canada Lowers Legend Biotech (NASDAQ:LEGN) Price Target to $62.00 - Defense World

Mar 13, 2026

Mar 12, 2026

Legend Biotech Plans to List in HK as Early as This Yr, Raising at Least US$300M: Wire - aastocks.com

Mar 12, 2026

Mar 11, 2026

RBC Capital lowers Legend Biotech stock price target on model updates By Investing.com - Investing.com South Africa

Mar 11, 2026

Mar 11, 2026

RBC Capital lowers Legend Biotech stock price target on model updates - Investing.com India

Mar 11, 2026

Mar 10, 2026

Legend Biotech Q4 2025 slides: CARVYKTI turns profitable, $555M sales By Investing.com - Investing.com South Africa

Mar 10, 2026

Mar 10, 2026

Raymond James reiterates Legend Biotech stock rating on strong Q4 results - Investing.com India

Mar 10, 2026

Mar 10, 2026

Truist reiterates Buy on Legend Biotech stock, $70 target on capacity - Investing.com

Mar 10, 2026

Mar 10, 2026

Jefferies reiterates Legend Biotech stock rating on Carvykti sales - Investing.com India

Mar 10, 2026

Mar 10, 2026

Jefferies reiterates Legend Biotech stock rating on Carvykti sales By Investing.com - Investing.com South Africa

Mar 10, 2026

Mar 10, 2026

Legend Biotech Q4 Earnings Call Highlights - Yahoo Finance

Mar 10, 2026

Mar 10, 2026

Legend Biotech Q4 2025 slides: CARVYKTI turns profitable, $555M sales - Investing.com India

Mar 10, 2026

Mar 10, 2026

Earnings call transcript: Legend Biotech Q4 2025 shows strong growth By Investing.com - Investing.com India

Mar 10, 2026

Mar 10, 2026

Earnings call transcript: Legend Biotech Q4 2025 shows strong growth - Investing.com

Mar 10, 2026

Mar 10, 2026

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Mar 10, 2026